Literature DB >> 23867639

Spectroscopic investigations of the charge-transfer interaction between the drug reserpine and different acceptors: towards understanding of drug-receptor mechanism.

Hala H Eldaroti1, Suad A Gadir, Moamen S Refat, Abdel Majid A Adam.   

Abstract

The study of the charge-transfer interaction of the drugs may be useful in understanding the drug-receptor interactions and the mechanism of drug action. Structural and thermal stability of charge-transfer (CT) complexes formed between the drug reserpine (Res) as a donor and quinol (QL), picric acid (PA), tetracyanoquinodimethane (TCNQ) or dichlorodicyanobenzoquinone (DDQ) as acceptors were reported. Elemental analysis, electronic absorption, spectrophotometric titration, IR, Raman, (1)H NMR and X-ray powder diffraction (XRD) were used to characterize the new products. The thermal stability of the synthesized CT complexes was investigated using thermogravimetric (TG) analyses, and the morphology and particle size of these complexes were obtained from scanning electron microscopy (SEM). The stoichiometry of the complexes (donor:acceptor molar ratio) was determined to be 1:1 for all complexes. Accordingly the formed CT complexes could be formulated as [(Res)(QL)], [(Res)(PA)], [(Res)(TCNQ)] and [(Res)(DDQ)]. It was found that the obtained CT complexes are nanoscale, semi-crystalline particles, thermally stable and formed through spontaneous reaction. The results obtained herein are satisfactory for estimation of drug Res in the pharmaceutical form.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Charge-transfer complexes; Reserpine; SEM; Thermal analysis; XRD

Mesh:

Substances:

Year:  2013        PMID: 23867639     DOI: 10.1016/j.saa.2013.06.046

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  6 in total

1.  Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part III: A green protocol for facile synthesis of complexes with TCNQ, DDQ, and TFQ acceptors.

Authors:  Abdel Majid A Adam; Hosam A Saad; Amnah M Alsuhaibani; Moamen S Refat; Mohamed S Hegab
Journal:  J Mol Liq       Date:  2021-04-22       Impact factor: 6.165

2.  Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part II: Complexation with several π-acceptors (PA, CLA, CHL).

Authors:  Abdel Majid A Adam; Hosam A Saad; Amnah M Alsuhaibani; Moamen S Refat; Mohamed S Hegab
Journal:  J Mol Liq       Date:  2020-12-23       Impact factor: 6.165

3.  Charge-transfer chemistry of two corticosteroids used adjunctively to treat COVID-19. Part I: Complexation of hydrocortisone and dexamethasone donors with DDQ acceptor in five organic solvents.

Authors:  Abdel Majid A Adam; Hosam A Saad; Moamen S Refat; Mohamed S Hegab
Journal:  J Mol Liq       Date:  2022-04-08       Impact factor: 6.633

4.  Charge-transfer chemistry of two corticosteroids used adjunctively to treat COVID-19. Part II: The CT reaction of hydrocortisone and dexamethasone donors with TCNQ and fluoranil acceptors in five organic solvents.

Authors:  Moamen S Refat; Bander Albogami; Abdel Majid A Adam; Hosam A Saad; Amnah Mohammed Alsuhaibani; Lal Miyan; Mohamed S Hegab
Journal:  J Mol Liq       Date:  2022-07-21       Impact factor: 6.633

5.  Attempting to Increase the Effectiveness of the Antidepressant Trazodone Hydrochloride Drug Using π-Acceptors.

Authors:  Walaa F Alsanie; Majid Alhomrani; Abdulhakeem S Alamri; Hussain Alyami; Sonam Shakya; Hamza Habeeballah; Heba A Alkhatabi; Raed I Felimban; Abdulwahab Alamri; Abdulhameed Abdullah Alhabeeb; Bassem M Raafat; Moamen S Refat; Ahmed Gaber
Journal:  Int J Environ Res Public Health       Date:  2022-09-08       Impact factor: 4.614

6.  Enhancing the Antipsychotic Effect of Risperidone by Increasing Its Binding Affinity to Serotonin Receptor via Picric Acid: A Molecular Dynamics Simulation.

Authors:  Majid Alhomrani; Walaa F Alsanie; Abdulhakeem S Alamri; Hussain Alyami; Hamza Habeeballah; Heba A Alkhatabi; Raed I Felimban; John M Haynes; Sonam Shakya; Bassem M Raafat; Moamen S Refat; Ahmed Gaber
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.